ABOUT US
Medicover Genetics is a leading healthcare company specialising in genetic medicine, with over 25 years of experience in genetics diagnostics. Medicover Genetics offers genetic testing services and genetic counselling, proprietary CE-IVD Next Generation Sequencing solutions and a versatile Technology Transfer Platform which enables partners to perform high-fidelity genetic tests in-house. With services across Europe, Asia, and Africa, the company empowers laboratories, healthcare professionals and patients to place genetics at the core of medical decisions. Committed to enhancing health and well-being, Medicover Genetics provides meaningful and actionable diagnostic solutions, improving disease prognosis, clinical management, and therapy selection for genetic disorders. The laboratories are CAP and ISO 15189 accredited, ISO 9001, and ISO 13485 certified, and comply with GMP and GCP, ensuring the highest quality standards.
Medicover Genetics is part of Medicover, a leading international healthcare and diagnostic services company founded in 1995 and listed on Nasdaq Stockholm. For more information, visit www.medicover.com
OUR PORTFOLIO
Medicover Genetics offers an extensive genetic testing portfolio to help health care professionals identify the most appropriate genetic test for their patients.
Spanning cytogenetic analyses, molecular pathology solutions, the latest in Next Generation Sequencing (NGS) technology and microbiome sequencing, Medicover Genetics offers a complete in-house and tailormade portfolio produced in our laboratories in Germany and Cyprus and offered internationally.
In addition to being your genetic testing partner, Medicover Genetics offers technology transfer and CE-IVD kits for our laboratory partners of any size, to perform genetic testing in-house. Our technology transfer utilizes Medicover Genetics’ proprietary technology and protocols to enable laboratories to set up and deploy high fidelity non-invasive prenatal tests, VERACITY and VERAgene. Our TarCET IVD kits are CE marked, next generation sequencing products intended to be used for identification of genetic variants associated with diseases and are designed to run one single assay for all tests. TarCETs and technology transfer offer an end-to-end CE-IVD solution using fully validated workflows including NGS library preparation, hybridization protocols and data analyses software.
Contact us to learn more about our solutions and how they can help you provide optimal genetic testing services for your partners!
Our clinical team comprised of scientist, physicians and medical geneticists, several with >20 years of experience in genetic testing, assuring meaningful and comprehensive genetic tests
SCIENCE
Our team has a very strong scientific publication track record in the field of genetic testing. Our scientists have published several original articles in prestigious peer-reviewed journals describing our innovative scientific work and cutting-edge technological advances.
Check our our latest publications, presentations and research grants here.
ACCREDITATIONS
Our company is assessed by several certified bodies. See all our accreditations here.
NEWSROOM
Medicover Genetics has successfully renewed its accreditation from the College of American Pathologists (CAP) following a comprehensive on-site inspe…
This year marks a major milestone for Medicover Genetics as we celebrate ten years of VERACITY, our advanced new generation non-invasive prenatal tes…
22 October 2025 – Medicover is proud to announce additional results from the ongoing DART clinical study from Oslo University Hospital. The study uti…
14 October 2025 – Medicover Genetics is pleased to announce new clinical data of its proprietary circulating tumor DNA-based minimal residual disease…
Medicover Genetics is pleased to highlight ebiom+, an advanced solution for endometrial microbiome analysis introduced earlier this year. The endo…
Medicover Genetics is pleased to announce the publication of an article coauthored by PD Dr. Markus Stumm in Geburtshilfe und Frauenheilkunde, the of…
Another Year of ESHRE, Another Step Forward in Reproductive Innovation From June 29 to July 2, the Medicover Genetics team proudly participated in…
Nicosia, Cyprus – July 9, 2025 – Medicover Genetics Cyprus welcomed students, teachers, and parents from across the island to celebrate the winne…
Medicover Genetics’ expands its testing portfolio by launching comprehensive pharmacogenomic testing
July 2025 – Medicover Genetics is pleased to announce the launch of Pharmacogenomic Preventive and Diagnostic Testing, comprehensive pharmacogenetics…
26 June 2025, Medicover Genetics was recently profiled in GenomeWeb for its pioneering work in minimal residual disease (MRD) diagnostics. The articl…
CAREERS
We promise an exciting team that works towards empowering people to use comprehensive and meaningful genetic tests at the forefront of their diagnostic journey, fueled by our vision to place genetics at the core of medical decisions. We want to achieve this by leveraging advancements in genomics to develop relevant diagnostic solutions, supported by professional medical interpretation, to improve people’s health and well-being.
Our genetic laboratories in Berlin and Munich, rely on the expertise of a highly motivated team of medical and scientific staff as well as the most modern methods of laboratory diagnostics for the diagnosis of hereditary conditions.
Our strategic product, marketing and sales teams work together to develop innovative products and bring them to patients and physicians across our Medicover countries and beyond.
To strengthen our team and meet the demands arising from our growth, we invite talented and ambitious scientists, marketing and sales people to send their CV by clicking on the link below.
See all our open positions here.
